Deep brain stimulation of the pallidofugal pathways to rescue severe brittle dyskinesias after STN-DBS lead implantation
Objective: To present a case with a severe life-threatening microlesion effect related with STN DBS rescued with a tractography-guided neuromodulation approach Background: Microlesion effect have…Hyperkinetic Movement Disorders after Thalamic Lesions
Objective: To describe delayed hyperkinetic movement disorder after a thalamic lesion. Background: Lesions in the basal ganglia circuit can cause abnormal movement disorders. After thalamic…Hemiparkinsonism Due to Diencephalic Lesion with 24 Years of Levodopa Response and Only Mild Dyskinesia
Objective: To present a case of a long-standing hemiparkinsonism due to cerebral lesion with a continuous response to a stable dose of levodopa with only…Ziconotide-Induced Orolingual Dyskinesia: A Case Series
Objective: Our aim is to report three cases of orolingual dyskinesia in adults receiving intrathecal ziconotide for chronic pain management. Background: Ziconotide (ZCN), a nonopioid…Effect of Levodopa-Carbidopa Intestinal Gel Versus Optimized Medical Treatment on Dyskinesia in Advanced Parkinson’s Disease Patients: Final Results of the Randomized 12-Week DYSCOVER Study
Objective: This study evaluated the effectiveness of LCIG versus optimized medical treatment (OMT) on the duration and severity of dyskinesia in aPD patients. Background: Approximately…The utility of single dose levodopa challenges in the management of Parkinson’s disease
Objective: To retrospectively review the clinical utility of single dose levodopa challenges in the management of Parkinson in a tertiary movement disorder clinic. Background: Acute…Early-onset peak dose Levodopa induced dyskinesia in elderly Ethiopian Parkinson’s disease patient
Objective: The aim was to report an early onset peak dose dyskinesia in a 55 years old Parkinson's disease patient who was naive to treatment…Safety and efficacy of istradefylline, an adenosine A2A receptor antagonist, as a function of baseline dyskinesia (BL-dyskinesia) in Parkinson’s disease (PD): A pooled analysis of 4 studies
Objective: To evaluate the effect of BL-dyskinesia on the efficacy and safety of istradefylline in 4 randomized, placebo-controlled, double-blind, phase 2b/3 trials. Background: Istradefylline, a…MDS Translation Program for MDS-UPDRS, UDysRS, and MDS-NMS
Objective: To summarize the status of the ongoing MDS-sponsored translation programs for non-English versions of the MDS-UPDRS, UDysRS, and MDS-NMS. Background: The MDS-UPDRS, UDysRS, and…Movement Disorders in the Plain People
Objective: Genomic discovery often occurs in large institutions, but the contribution of small, rural genetics clinics must not be overlooked. While rare, these rural genetics…
- « Previous Page
- 1
- …
- 21
- 22
- 23
- 24
- 25
- …
- 49
- Next Page »